CVE-2026-10255: Pharmacy Sales System Authentication Bypass – SourceCodester 1.0

Technical summary

CVE-2026-10255 affects the sell_statement function within application/controllers/ShowForm.php in SourceCodester Pharmacy Sales and Inventory System 1.0. The vulnerability stems from improper access controls (CWE-284) and insufficient permission verification (CWE-266), allowing an unauthenticated network-based attacker to bypass authorization mechanisms. The attack surface is unrestricted (no authentication prerequisite, no UI interaction required), resulting in confidentiality impact through unauthorized information disclosure. The CVSS 3.1 score of 5.3 (MEDIUM) reflects low-to-moderate risk: network-exploitable with no preconditions, but limited to read-access of data rather than modification or system availability impact.

Business impact

Unauthorized access to pharmacy sales and inventory data creates multiple business risks. Patient medication purchase history, prescription patterns, and potentially personally identifiable information may be exposed to competitors or malicious actors. This exposure can trigger privacy compliance violations (HIPAA, regional data protection laws), reputational harm, and loss of customer trust. Organizations running this system should assume confidentiality has been compromised and assess what customer, patient, and operational data has been accessed or is accessible through this vector.

Affected systems

SourceCodester Pharmacy Sales and Inventory System version 1.0 is confirmed vulnerable. No patched version number is currently available in vendor advisories; organizations using this product should contact SourceCodester for guidance on remediation timelines or workarounds. The vulnerability affects all deployments regardless of configuration, since the flaw is in the application code itself rather than dependent on specific server settings.

Exploitability

Exploitability is high in practical terms. The vulnerability requires no authentication, no user interaction, and no special network access—an attacker needs only network connectivity to the affected application. The CVSS Access Vector (AV:N) and Attack Complexity (AC:L) confirm ease of triggering. Public disclosure of exploit code significantly increases the likelihood of opportunistic scanning and exploitation by attackers with minimal sophistication. This is not a theoretical risk.

Remediation

Immediate action is required. Organizations should prioritize updating to a patched version as soon as SourceCodester releases one; verify the vendor advisory for available releases. Until an update is available, implement network-level access controls to restrict direct connectivity to the affected application—use firewalls, VPNs, or reverse proxies to allow only trusted internal users or IP ranges. Conduct a data access audit to identify what sales and inventory records may have been viewed through this function. Monitor application logs for unusual access patterns to ShowForm.php or the sell_statement endpoint.

Patch guidance

Check SourceCodester's official security advisory and download page for version updates addressing CVE-2026-10255. Verify that the patched version explicitly mentions this CVE in its release notes. Test patches in a non-production environment before deployment to ensure compatibility with your pharmacy workflows and any customizations. If no official patch is available yet, maintain contact with the vendor for status updates and confirm expected remediation timeline.

Detection guidance

Monitor HTTP request logs and application access logs for direct calls to ShowForm.php with focus on the sell_statement function parameter. Look for requests lacking valid authentication tokens or session identifiers, especially repeated or automated attempts. Implement intrusion detection signatures targeting GET/POST requests to the vulnerable endpoint. Log and alert on any access to inventory or sales data retrieval functions by unauthenticated sessions. Review access control lists and verify that ShowForm.php requires authentication before processing any user input.

Why prioritize this

Although the CVSS score is MEDIUM (5.3), several factors elevate practical priority: (1) publicly available exploit code removes the barrier to active exploitation, (2) affected data—pharmacy sales and patient information—carries high regulatory and reputational sensitivity, (3) the attack is trivially easy to execute with no preconditions, and (4) SourceCodester is a small-footprint system often deployed in small-to-medium healthcare operations with limited security infrastructure. Organizations using this product should treat this as a near-term remediation target despite the moderate numeric score.

Risk score, explained

The CVSS 3.1 score of 5.3 reflects a confidentiality-only impact (no integrity or availability compromise) accessible over the network with no authentication or user interaction required. The MEDIUM rating is appropriate from a pure technical perspective. However, the business context—healthcare data, public exploit availability, and typical deployment in resource-constrained settings—warrants treating this with urgency in prioritization decisions. Do not allow the MEDIUM label to create false comfort; escalate to decision-makers responsible for pharmacy system security.

Frequently asked questions